Simplex Trading, LLC Kinnate Biopharma Inc. Transaction History

Simplex Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$2.24 - $2.66 $50,568 - $60,049	-22,575 Reduced 50.91%	21,764 $57,000
Q4 2023 Feb 02, 2024	BUY	$1.07 - $2.5 $47,442 - $110,847	44,339 New	44,339 $105,000
Q2 2023 Aug 04, 2023	SELL	$2.33 - $6.84 $16,710 - $49,056	-7,172 Reduced 59.33%	4,917 $14,000
Q1 2023 Apr 27, 2023	BUY	$3.46 - $7.98 $39,793 - $91,777	11,501 Added 1955.95%	12,089 $75,000
Q4 2022 Feb 02, 2023	SELL	$5.26 - $12.19 $4,765 - $11,044	-906 Reduced 60.64%	588 $3,000
Q3 2022 Nov 04, 2022	BUY	$9.86 - $15.76 $14,592 - $23,324	1,480 Added 10571.43%	1,494 $17,000
Q2 2022 Aug 03, 2022	BUY	$7.43 - $13.0 $104 - $182	14 New	14 $0

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.